Fermina Mazzella, MD
Hematology · Newark, NJNPI 1275522344
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $48,860 of the $49,030 with a category attached, or 99.7%. Takeda Pharmaceuticals U.S.A., Inc. accounts for 99.7% of it on its own, with 5 other manufacturers making up the rest. 2025 is the largest year on record at $29,760, more than ten times the $17 reported in 2019. Among hematology clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 26 payments — averaging $1885.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$49K
- Siemens Medical Solutions USA, Inc.$72
- Roche Diagnostics Corporation$40
- Phadia US Inc.$30
- Abbott$17
- Beckman Coulter, Inc.$12
Across 2 payments — averaging $20,000 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Diasorin Inc.$40K
What the payments were for
- Consulting fees$48,860100%
- Food & beverage$1700%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 19 | $48,860 |
| Siemens Medical Solutions USA, Inc. | 2 | $72 |
| Roche Diagnostics Corporation | 2 | $40 |
| Phadia US Inc. | 1 | $30 |
| Abbott | 1 | $17 |
| Beckman Coulter, Inc. | 1 | $12 |
How this compares
$49,030 in reported general payments places this provider in the 95th percentile of 43 hematology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other hematology in Newark
- Rose SnyderNewark$2K
- Marshall McKennaNewark$400
- Ahmed GalalMorristown$1.7M
- Mansi ShahNew Brunswick$131K
- Muhammad AbbasiMountain Lakes$22K
- Robert TassanWestwood$21K
- Marcus CarrNorth Brunswick$19K
- Jason LevitzMountain Lakes$19K
- Christopher TullyMountain Lakes$17K
- Claire PhilippNew Brunswick$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.